Novo Integrated Sciences Financials

Novo Integrated Stock Summary

Novo Integrated competes with Aveanna Healthcare, P3 Health, IMAC Holdings, Oncology Institute, and Lifestance Health. Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc. Novo Integrated operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.

Novo Integrated Key Financial Ratios

There are many critical financial ratios that Novo Integrated's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Novo Integrated Sciences reports annually and quarterly.

Novo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Novo Integrated's current stock value. Our valuation model uses many indicators to compare Novo Integrated value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novo Integrated competition to find correlations between indicators driving Novo Integrated's intrinsic value. More Info.Novo Integrated Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novo Integrated's earnings, one of the primary drivers of an investment's value.

Novo Integrated Market Pulse

Along with financial statement analysis, the daily predictive indicators of Novo Integrated help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novo Integrated Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novo Integrated Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Novo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novo Integrated's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.